PATIENT EDUCATION
Conditions
Keywords
Asthma, Self Efficacy, Medication Adherence, Mobile Education, Sleep
Brief summary
Asthma patients with recurrent airway obstruction frequently exhibit poor symptom control, characterized by treatment non-adherence and sleep-wake cycle disturbances. A nurse-led mobile health education intervention may address these challenges by enhancing collaborative disease management, enabling remote patient monitoring, and strengthening self-management competencies. The AstımAsistan application was designed to monitor changes in patient self-efficacy, medication adherence, and sleep quality through three core features: (1) patient education modules, (2) breathing exercise/medication reminders, and (3) mobile consultation capabilities. Study data were collected using four instruments: (1) the Participant Information Form, (2) the Chronic Disease Self-Efficacy Scale, (3) the Medication Adherence Reporting Scale, and (4) the Pittsburgh Sleep Quality Index. The mobile education-based application was developed following the ADDIE (Analysis, Design, Development, Implementation, and Evaluation) instructional design model.
Interventions
BEHAVIORALMobile education
It consists of participants who will download the mobile patient education and breathing exercise reminder program and apply it for 10 weeks.
Sponsors
Gulhane Training and Research Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Masking description
Randomization will be performed according to disease duration via calculatorsoup.com, a web-based program. It will be defined as the intervention group (M) and the control group (K). During the randomization process, numbered envelopes will be prepared by an academician outside the research for the patients included in the intervention and control groups. The researcher will learn the information about the intervention or control group in the prepared envelopes when the relevant envelope is opened during the interview with the patient. Thus, statistical blinding will be ensured.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
1. Being between the ages of 18-65 2. Having been diagnosed with asthma at least 6 months ago 3. Being treated for asthma in oral, inhaler or injection forms 4. Being literate in Turkish 5. Having an Android phone on which the mobile application can be installed and being able to use the phone 6. Having mobile network or wireless internet access 7. Volunteering to participate in research 8. Living in Ankara
Exclusion criteria
1. Being hospitalized for asthma treatment 2. Having a language barrier that hinders communication 3. Being diagnosed with COPD 4. Being diagnosed with a psychiatric disease 5. Being on psychoactive or opioid therapy 6. Being diagnosed with a sleep disorder related to non-respiratory reasons (physical and psychological) and being treated
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Chronic Disease Self-Efficacy | 10 weeks | Chronic Disease Self Efficacy Scale: In this 30-item scale, each question is scored between 1 and 10 points to determine the level of self-efficacy. The total score obtained by the individual from the scale is divided by the number of items to calculate an overall self-efficacy average. The scale also has 10 subtitles. If the 30 items' average is below 7, it means the individual has low self-efficacy. If the average is 7 or above, it indicates that the individual has high self-efficacy regarding their illness and believes they can achieve their goals. |
| Medication Adherence | 10 weeks | The Medication Adherence Report Scale (MARS), developed by Horne and Hankins (2001), can be adapted based on disease type. The scale requires participants to indicate the frequency of occurrence for 5 specific statements in themselves. The scoring uses a Likert-type scale where: 5=never, 4=rarely, 3=sometimes, 2=often, and 1=always. The total test score is obtained by summing the scores from all items. The minimum possible score on the scale is 5, and the maximum is 25. Higher scores indicate compliance, while lower scores suggest non-compliance. |
| Sleep Quality | 10 weeks | PSQI is developed by Buysse et al. in 1989, this scale is used to assess sleep quality and identify factors contributing to sleep disorders. Its validity and reliability for our country were established by Ağargün et al. The scale consists of 18 scored items grouped into 7 component scores, with each item rated on a 0-3 scale. The components are: Subjective Sleep Quality Sleep Latency Sleep Duration Habitual Sleep Efficiency Sleep Disturbances Use of Sleep Medication Daytime Dysfunction The total scale score is calculated by summing the seven component scores. A total score of 5 or higher indicates poor sleep quality. |
Countries
Turkey (Türkiye)
Outcome results
None listed